Conference Date & Venue

January 15, 2027 – January 16, 2027

Kimpton Hotel Palomar Phoenix

2 East Jefferson Street
Phoenix, AZ 85004

Support Construction of Binaytara's Cancer Hospital in Nepal

Event Description

The Best of Hematology and Breast Cancer™ 2027, Phoenix is a CME/CE-accredited, in-person cancer conference. This annual hematology and oncology conference brings together physicians, nurses, pharmacists, and other healthcare professionals to review the most recent advancements in the management of hematologic malignancies and breast cancer.

Drawing on groundbreaking data from the 68th American Society of Hematology (ASH26) Annual Meeting and the San Antonio Breast Cancer Symposium (SABCS26), this two-day oncology symposium delivers high-impact updates that can be directly applied to clinical practice. Through a dynamic mix of didactic lectures, case-based discussions, tumor board-style reviews, and interactive debates, participants will explore evolving standards of care, new treatment strategies, and real-world applications for improving outcomes.

By emphasizing a multidisciplinary approach, the program is designed not only for oncologists and hematologists but also for physician assistants, nurse practitioners, pharmacists, nurses, and all members of the cancer care team. In addition, networking breaks, exhibits, and receptions offer opportunities to collaborate with peers, learn from thought leaders, and connect with industry partners.

Target Audience                               

  • Medical Oncologists / Hematologists
  • Surgical Oncologists
  • Radiation Oncologists
  • Pathologists
  • Oncology Fellows
  • Oncology Nurses
  • Nurse Practiotioners
  • Physician Assistants
  • Oncology Pharmacists

 

 

Contact Us   

Phone: 425-361-0029

Email: sponsorships@binaytara.org


 

About Binaytara

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses. 

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.